subject: Biostar Pharmaceuticals, Inc. (bspm) - Financial And Strategic Analysis Review --- Aarkstore [print this page] BioStar Pharmaceuticals, IncBioStar Pharmaceuticals, Inc. (BSPM) - Financial and Strategic Analysis Review
BioStar Pharmaceuticals, Inc. (BioStar) is a pharmaceutical company engaged in development, manufacture, and marketing of pharmaceutical and medical nutrient products for various diseases and conditions. It operates through its wholly owned subsidiary Shaanxi Aoxing Pharmaceutical Co., Ltd. Xin Ao Xing Oleanolic Acid Capsule is the company's lead product, which is an over-the-counter medicine used for the treatment of chronic hepatitis B. Recently, BioStar received a patent from China's State Intellectual Property Bureau for its Aoxing Ganbao product, which is a traditional Chinese herbal product that is complementary for its flagship Xin Aoxing Oleanolic Acid Capsule to treat Hepatitis B.
BioStar Pharmaceuticals, Inc. Key Recent Developments
May 17, 2010: Biostar Pharmaceuticals Reports Net Income Of $2.3 Million For Q1 2010
Apr 22, 2010: Biostar Receives Approval For Listing On NASDAQ Global Market
Apr 05, 2010: Biostar Pharmaceuticals FY 2009 Net Sales Up
Jan 04, 2010: Biostar Establishes Board Committees And Appoints New Directors
Dec 29, 2009: Biostar To Introduce Xin Aoxing Oleanolic Acid Capsules In Beijing, Shanghai
This comprehensive SWOT profile of BioStar Pharmaceuticals, Inc. provides you an in-depth strategic analysis of the companys businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the companys key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
This company report forms part of the Profile on Demand service, covering over 50,000 of the worlds leading companies. Once purchased, the highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of BioStar Pharmaceuticals, Inc., including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days (excluding weekends).
The profile contains critical company information including*,
- Business description A detailed description of the companys operations and business divisions.
- Corporate strategy Analysts summarization of the companys business strategy.
- SWOT Analysis A detailed analysis of the companys strengths, weakness, opportunities and threats.
- Company history Progression of key events associated with the company.
- Major products and services A list of major products, services and brands of the company.
- Key competitors A list of key competitors to the company.
- Key employees A list of the key executives of the company.
- Executive biographies A brief summary of the executives employment history.
- Key operational heads A list of personnel heading key departments/functions.
- Important locations and subsidiaries A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
